Blood Screening Workshop Considers Long-Term Potential Of Microarrays
This article was originally published in The Gray Sheet
Executive Summary
Blood banks will not use microarray targeted sequence analysis assays for blood viral screening until the assays are automated, cost effective and highly sensitive for a wide range of viral gene sequences, America's Blood Centers Executive VP, Celso Bianco, MD, states